The expertise of Oxford PharmaGenesis in planning and communicating real-world evidence (RWE) was showcased in a leader published online this month by eyeforpharma. The article ‘Mind the Gap’ quoted extensively from an interview with Oxford PharmaGenesis Commercial Director Richard White, alongside other prominent industry figures in the RWE arena including Peter Speyer, Global Head of RWE Solutions at Novartis.
“Oxford PharmaGenesis brings a wealth of experience to help our clients meet the increasing need for effective planning and communication of RWE,” said Richard White. “The eyeforpharma article is timely as it highlights that the barriers to success are often internal – indeed, much of the work we do involves helping our clients to build internal awareness of, and capabilities in, RWE.”
The Oxford PharmaGenesis insights into the challenges to acceptance of RWE in informing healthcare decision-making were recently highlighted in an invited editorial, published online in the Journal of Comparative Effectiveness Research (http://www.futuremedicine.com/doi/full/10.2217/cer-2016-0070), and Richard White will be presenting on this topic at forthcoming meetings of the International Society for Medical Publication Professionals (ISMPP; London, 18 January 2017) and the Trends in Publication Planning Association (TIPPA, Annual International Publication Planning Meeting; San Diego, USA, 21 February 2017).
Click here for further information on Oxford PharmaGenesis RWE offerings, and click here to find out more about our SURE™ methodology for identifying the best real-world data sources for your evidence planning needs.
